Page last updated: 2024-10-21

phenytoin and Andersen Syndrome

phenytoin has been researched along with Andersen Syndrome in 1 studies

Andersen Syndrome: A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.

Research Excerpts

ExcerptRelevanceReference
"Phenytoin was considered for control of symptomatic VA in three patients."1.51Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype. ( Augustine, AJ; Bhavani, GS; Girisha, KM; Kamath, P; Kedambadi, RC; Pai, R; Pasha, SW; Prabhu, MA; Rai, MK, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rai, MK1
Pai, R1
Prabhu, MA1
Pasha, SW1
Kedambadi, RC1
Kamath, P1
Augustine, AJ1
Bhavani, GS1
Girisha, KM1

Other Studies

1 other study available for phenytoin and Andersen Syndrome

ArticleYear
Short-term response to phenytoin sodium in Andersen-Tawil syndrome-1 with a cardiac-dominant phenotype.
    Pacing and clinical electrophysiology : PACE, 2019, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Algorithms; Andersen Syndrome; Arrhythmias, Cardiac; Female; Humans; Male; Pedigr

2019